The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 2, 1997, Pages 831-838

  Tesson, Frédérique ^a   Dufour, Cécile ^a   Moolman, Johanna C ^b   Carrier, Lucie ^a   Al Mahdawi, Sahar ^c   Chojnowska, Lidia ^d   Dubourg, Olivier ^a   Soubrier, Florent ^e   Brink, Paul ^b   Komajda, Michel ^a   Guicheney, Pascale ^a   Schwartz, Ketty ^a   Feingold, Josué ^f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d INSTITUTE OF CARDIOLOGY   (Poland)

^e Groupe Hospitalier Saint Louis   (France)

^f INSERM   (France)

Author keywords

Angiotensin I converting enzyme; Hypertrophic cardiomyopathy; Mutation; Myosin binding protein C; Myosin heavy chain; Polymorphism; Sarcomeric protein

Indexed keywords

BINDING PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; MYOSIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BINDING SITE; CODON; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HEART VENTRICLE SEPTUM; HETEROZYGOTE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MOLECULAR GENETICS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031080069     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0332     Document Type: Article

References (35)

1. AL-MAHDAWI S, CHAMBERLAIN S, CHOJNOWSKA L, MICHALAK E, NIHOYANNOPOULOS P, RYAN M, KUSNIERCZYK B, FRENCH JA, GILLIGAN DM, CLELAND J, WILLIAMSON R, RUZYLLO W, OAKLEY C, 1994. The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J 72: 105-111.
2. BAKER KM, ACETO JF, 1990. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 259: H610-H618.
3. BONNE G, CARRIER L, BERCOVICI J, CRUAUD C, RICHARD P, HAINQUE B, GAUTEL M, LABEIT S, JAMES M, BECKMANN J, WEISSENBACH J, VOSBERG H-P, FISZMAN M, KOMAJDA M, SCHWARTZ K, 1995. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Genet 11: 438-440.
4. CARRIER L, RICHARD P., BONNE G, BERCOVICI J, TESSON F, LAUTIÉ N, FORISSIER J-F, HAINQUE B, BENNACEUR M, GUICHENEY P, KOMAJDA M, SCHWARTZ K, 1995. Distribution of disease loci in twenty eight French families with familial hypertrophic cardiomyopathy. Circulation 92: 1-232.
5. CIRO E, NICHOLS PF, MARON BJ, 1983. Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy: two-dimensional echocardiographic analysis. Circulation 67: 1227-1233.
6. DAUSSE E, KOMAJDA M, FETLER L, DUBOURG O, DUFOUR C, CARRIER L, WISNEWSKY C, BERCOVICI J, HENGSTENBERG C, AL-MAHDAWI S, ISNARD R, HAGEGE A, BOUHOUR JB, DESNOS M, BECKMANN J, WEISSENBACH J, SCHWARTZ K, GUICHENEY P, 1993. Familial hypertrophic cardiomyopathy: microsatellite haplotyping and identification of a hot-spot for mutations in the β-myosin heavy chain gene. J Clin Invest 92: 2807-2813.
7. DUFOUR C, DAUSSE E, FETLER L, DUBOURG O, BOUHOUR JB, VOSBERG H-P, GUICHENEY P, KOMAJDA M, SCHWARTZ K, 1994. Identification of a mutation near a functional site of the β cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. J Mol Cell Cardiol 9: 1241-1247.
8. EPSTEIN ND, FANANAPAZIR L, LIN HJ, MULVIHILL J, WHITE R, LALOUEL J-M, LIFTON RP, NIENHUIS AW, LEPPERT M, 1992. Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy. Circulation 85: 635-647.
9. FANANAPAZIR L, EPSTEIN ND, 1994. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation 89: 22-32.
10. FOGARTY DG, MAXWELL AP, DOHERTY CC, HUGHES AE, NEVIN NC, 1994. ACE gene typing. Lancet 343: 851.
11. FREIBURG A, GAUTEL M, 1996. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem 235: 317-323.
12. GEISTERFER-LOWRANCE AAT, KASS S, TANIGAWA G, VOSBERG H-P, McKENNA W, SEIDMAN CE, SEIDMAN JG, 1990. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation. Cell 62: 999-1006.
13. KLUES HG, SCHIFFERS A, MARON BJ, 1995. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26: 1699-1708.
14. KOSHIDA S, KURASAWA M, YASUDA M, SATO N, OBINATA T, 1995. Assembly of cardiac C-protein during myofibrillogenesis in myogenic cells in culture. Cell Struct Funct 20: 253-261.
15. LANKFORD EB, EPSTEIN ND, FANANAPAZIR L, SWEENEY HL. 1995. Abnormal contractile properties of muscle fibers expressing β-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 95: 1409-1414.
16. LECHIN M, QUINONES MA, OMRAN A, HILL R, Yu QT, RAKOWSKI H, WIGLE D, LIEW CC, SOLE M, ROBERTS R, MARIAN AJ, 1995. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 92: 1808-1812.
17. MARIAN AJ, Yu Q-T, WORKMAN R, GREVE G, ROBERTS R, 1993. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342: 1085-1086.
18. MARIAN AJ, Yu Q-T, MANN DL, GRAHAM FL, ROBERTS R, 1995. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circ Res 77: 98-106.
19. MARON BJ, BONOW RO, CANNON RO, LEON MB, EPSTEIN SE, 1987. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316: 780-789 and 844-852.
20. MOOLMAN JC, BRINK PA, CORFIELD VA, 1993. Identification of a new missense mutation at Arg 403, a CpG mutation hotspot, in exon 13 of the β-myosin heavy chain gene in hypertrophic cardiomyopathy. Hum Mol Genet 2: 1731-1732.
21. MOOLMAN JC, BRINK PA, CORFIELD VA, 1995. Identification of a novel Ala797Thr mutation in exon 21 of the β-myosin heavy chain gene in hypertrophic cardiomyopathy. Hum Mutat 6: 197-198.
22. 2 dopamine receptor locus. Arch Gen Psychiatry 48: 655-663.
23. POSEN BM, MOOLMAN JC, CORFIELD VA, BRINK PA, 1995. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac β myosin heavy chain gene mutations. Br Heart J 74: 40-46.
24. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F, 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346.
25. RIGAT B, HUBERT C, CORVOL P, SOUBRIER F, 1992. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20: 1433.
26. SADOSHIMA J, IZUMO S, 1993. Molecular characterization of angiotensin II induced hypertrophy of cardiac myocytes and hyperplasia of cardiac flbroblasts: critical role of the AT1 receptor subtype. Circ Res 73: 413-423.
27. SADOSHIMA J, Xu Y, SLAYTER HS, IZUMO S, 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984.
28. SOLOMON SD, WOLFF S, WATKINS H, RIDKER PM, COME P, MCKENNA WJ, SEIDMAN CE, LEE RT, 1993. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol 22: 498-505.
29. SPIELMAN RS, MCGINNIS RE, EWENS WJ, 1993. Transmission Test for Linkage Disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506-516.
30. THIERFELDER L, WATKINS H, MACRAE C, LAMAS R, MCKENNA W, VOSBERG H-P, SEIDMAN JG, SEIDMAN CE, 1994. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77: 701-712.
31. TIRET L, RIGAT B, VISVIKIS S, BREDA C, CORVOL P, CAMBIEN F, SOUBRIER F, 1992. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51: 197-205.
32. WATKINS H, CONNER D, THIERFELDER L, JARCHO JA, MACRAE C, MCKENNA WJ, MARON BJ, SEIDMAN JG, SEIDMAN CE, 1995a. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genet 11: 434-437.
33. WATKINS H, MCKENNA WJ, THIERFELDER L, SUK HJ, ANAN R, O'DONOGHUE A, SPIRITO P, MATSUMORI A, MORAVEC CS, SEIDMAN JG, SEIDMAN CE, 1995b. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332: 1058-1064.
34. YAMAZAKI T, KOMURO I, KUDOH S, ZOU Y, SHIOJIMA I, MIZUNO T, TAKANO H, HIROI Y, UEKI K, TOBE K, KADOWAKI T, NAGAI R, YAZAKI Y, 1995. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ Res 77: 258-265.
35. YONEYA K, OKAMOTO H, MACHIDA M, ONOZUKA H, NOGUCHI M, MIKAMI T, KAWAGUCHI H, MURAKAMI M, UEDE T, KITABATAKE A, 1995. Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am Heart J 130: 1089-1093.